Henry Schein (NASDAQ:HSIC) Issues Quarterly Earnings Results

Henry Schein (NASDAQ:HSICGet Rating) announced its quarterly earnings results on Tuesday. The company reported $1.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.19 by $0.11, RTT News reports. The business had revenue of $3.18 billion for the quarter, compared to analyst estimates of $3.12 billion. Henry Schein had a return on equity of 15.84% and a net margin of 5.09%. The company’s quarterly revenue was up 8.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.24 earnings per share.

HSIC stock opened at $80.45 on Tuesday. Henry Schein has a twelve month low of $70.25 and a twelve month high of $92.68. The company has a quick ratio of 0.86, a current ratio of 1.67 and a debt-to-equity ratio of 0.20. The stock’s 50 day moving average is $87.29 and its 200-day moving average is $80.39. The firm has a market capitalization of $11.11 billion, a PE ratio of 18.04, a P/E/G ratio of 1.41 and a beta of 0.75.

Several research analysts have issued reports on the company. Morgan Stanley increased their price target on Henry Schein from $67.00 to $72.00 and gave the stock an “underweight” rating in a report on Wednesday, February 16th. Robert W. Baird increased their price target on Henry Schein from $98.00 to $103.00 in a report on Wednesday, February 16th. Piper Sandler cut their price target on Henry Schein from $98.00 to $95.00 in a report on Friday, January 28th. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating and set a $95.00 price target on the stock. in a report on Tuesday, April 19th. Finally, StockNews.com began coverage on Henry Schein in a report on Thursday, March 31st. They issued a “buy” rating on the stock. One research analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average target price of $94.50.

In other Henry Schein news, Director Scott Philip Serota purchased 1,000 shares of the firm’s stock in a transaction that occurred on Friday, March 4th. The stock was bought at an average cost of $85.87 per share, with a total value of $85,870.00. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Mark E. Mlotek sold 24,075 shares of the firm’s stock in a transaction on Thursday, February 24th. The stock was sold at an average price of $82.99, for a total value of $1,997,984.25. The disclosure for this sale can be found here. Company insiders own 1.00% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in the business. MML Investors Services LLC increased its position in Henry Schein by 4.9% in the fourth quarter. MML Investors Services LLC now owns 8,405 shares of the company’s stock worth $652,000 after buying an additional 391 shares during the last quarter. Glenmede Trust Co. NA boosted its holdings in shares of Henry Schein by 8.7% in the fourth quarter. Glenmede Trust Co. NA now owns 7,786 shares of the company’s stock worth $603,000 after acquiring an additional 624 shares during the period. California State Teachers Retirement System boosted its holdings in shares of Henry Schein by 0.5% in the fourth quarter. California State Teachers Retirement System now owns 247,158 shares of the company’s stock worth $19,162,000 after acquiring an additional 1,188 shares during the period. LPL Financial LLC boosted its holdings in shares of Henry Schein by 9.6% in the fourth quarter. LPL Financial LLC now owns 19,334 shares of the company’s stock worth $1,502,000 after acquiring an additional 1,701 shares during the period. Finally, Comerica Bank boosted its holdings in shares of Henry Schein by 6.1% in the fourth quarter. Comerica Bank now owns 36,807 shares of the company’s stock worth $2,677,000 after acquiring an additional 2,132 shares during the period. 94.30% of the stock is owned by institutional investors and hedge funds.

Henry Schein Company Profile (Get Rating)

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Earnings History for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.